Valuation: Daewoong Co., Ltd.

Capitalization 1,092B 805M 695M 655M 592M 1.1B 68.92B 1.23B 7.61B 2.97B 31.67B 3.02B 2.96B 116B P/E ratio 2025 *
-
P/E ratio 2026 * -
Enterprise value 1.61B 1.18M 1.02M 963K 872K 1.61M 101M 1.82M 11.19M 4.37M 46.6M 4.44M 4.35M 170M EV / Sales 2025 *
0.74x
EV / Sales 2026 * 0.67x
Free-Float
31.94%
Yield 2025 *
0.75%
Yield 2026 * 0.75%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.11%
1 week-3.09%
Current month+5.33%
1 month+31.53%
3 months+37.35%
6 months+26.24%
Current year+23.61%
More quotes
1 week 26,200
Extreme 26200
28,650
1 month 18,870
Extreme 18870
28,650
Current year 17,420
Extreme 17420
28,650
1 year 15,050
Extreme 15050
28,650
3 years 11,460
Extreme 11460
29,000
5 years 11,460
Extreme 11460
86,700
10 years 6,470
Extreme 6470
86,700
More quotes
Manager TitleAgeSince
Chief Executive Officer 65 2015-03-19
Director of Finance/CFO 54 -
Comptroller/Controller/Auditor 64 2019-12-31
Director TitleAgeSince
Director/Board Member 65 2013-12-30
Director/Board Member 60 2022-03-28
Director/Board Member 68 2022-03-28
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.11%-3.09%+62.71%-5.32% 805M
+0.02%+0.51%+11.72%+103.47% 47.28B
-1.89%+6.98%+13.88%+62.69% 27.15B
-0.72%-2.34%+33.59% - 22.86B
+0.16%+0.07%-2.55%+57.65% 14.17B
-0.39%+1.54%-10.60%+177.17% 11.5B
+4.47%+16.34%+94.51%+108.26% 8.42B
-.--%+0.14% - - 6.79B
+0.27%+1.35%+37.73%+99.15% 6.65B
-.--%-1.95% - - 5.73B
Average +0.08%+2.04%+30.12%+86.15% 15.14B
Weighted average by Cap. -0.20%+2.25%+19.00%+94.98%
See all sector performances

Financials

2025 *2026 *
Net sales 2,166B 1.6B 1.38B 1.3B 1.18B 2.17B 137B 2.45B 15.09B 5.89B 62.82B 5.99B 5.86B 229B 2,421B 1.79B 1.54B 1.45B 1.31B 2.43B 153B 2.74B 16.87B 6.59B 70.23B 6.7B 6.56B 257B
Net income - -
Net Debt 515B 380M 328M 309M 279M 517M 32.51B 582M 3.59B 1.4B 14.94B 1.42B 1.39B 54.57B 522B 385M 332M 313M 283M 524M 32.95B 590M 3.64B 1.42B 15.14B 1.44B 1.41B 55.31B
More financial data * Estimated data
Logo Daewoong Co., Ltd.
Daewoong Co Ltd is a Korea-based holding company engaged in the manufacture and sale of pharmaceuticals. The Company operates its business mainly through subsidiaries including Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd, Daewoong Development Co Ltd, and Hanall Biopharma Co Ltd. Daewoong Pharmaceutical Co Ltd, Daewoong Bio Co Ltd and Hanall Biopharma Co Ltd are engaged in the manufacture and sale of pharmaceuticals. Daewoong Development Co Ltd is engaged in real estate rental and supply business. In addition, IDS&Trust Co Ltd manufactures and sells communication-related devices. Daewoong Life Science Co Ltd is engaged in food processing and sales. Pampaeg Co Ltd is engaged in the packaging business of quasi-drugs. Daewoong Management Development Institute Co Ltd is engaged in management and industrial training projects.
Employees
356
More about the company
Date Price Change Volume
25-06-12 26,700.00 -1.11% 115,758
25-06-11 27,000.00 -3.05% 114,620
25-06-10 27,850.00 +2.01% 166,201
25-06-09 27,300.00 -0.91% 153,300
25-06-05 27,550.00 -1.61% 152,557

End-of-day quote Korea S.E., June 11, 2025

More quotes
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26,700.00KRW
Average target price
28,000.00KRW
Spread / Average Target
+4.87%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A003090 Stock